C57BL/6JCya-Hspg2em1flox/Cya
Common Name:
Hspg2-flox
Product ID:
S-CKO-02997
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Hspg2-flox
Strain ID
CKOCMP-15530-Hspg2-B6J-VA
Gene Name
Product ID
S-CKO-02997
Gene Alias
HSPG; Pcn; Plc; per
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
4
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Hspg2em1flox/Cya mice (Catalog S-CKO-02997) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000171332
NCBI RefSeq
NM_008305
Target Region
Exon 2~3
Size of Effective Region
~1.9 kb
Detailed Document
Overview of Gene Research
Hspg2, also known as heparan sulfate proteoglycan 2, encodes perlecan, a multifunctional proteoglycan crucial for extracellular matrix integrity, tissue border maintenance, and regulation of various signaling pathways. It plays significant roles in many developmental processes like heart and brain formation, and is widely expressed in the musculoskeletal system [2].
In hypertrophic scar formation, TNFSF13 activates the NF-κB signaling pathway by interacting with Hspg2, regulating the proliferation, migration, fibrosis, and inflammatory response of hypertrophic scar fibroblasts. Mesenchymal stem cell-derived exosomes alleviate hypertrophic scar by inhibiting fibroblasts via the TNFSF-13/Hspg2 signaling pathway [1].
In human cardiomyocytes, perlecan (Hspg2 product) promotes structural, contractile, and metabolic development. Haploinsufficiency of Hspg2 in late-stage cardiomyocytes leads to structural, contractile, metabolic, and ECM gene dysregulation [3].
In bladder cancer, Hspg2 promotes tumor progression through the NID1/AKT signaling pathway [4].
In acute myeloid leukemia, Hspg2 overexpression is associated with poor prognosis and can be an independent prognostic biomarker [5].
Mutations in Hspg2 are associated with better immune checkpoint inhibitor outcomes in melanoma and non-small cell lung cancer, likely due to favorable immunocyte abundance and mutational burden [6].
Hspg2 may be a modifier gene for Marfan syndrome, as its expression correlates with disease severity in a mouse model [7].
Mutations in Hspg2 cause Schwartz-Jampel syndrome type 1, a rare musculoskeletal disorder [8].
Polymorphisms in Hspg2 are associated with intracranial aneurysm susceptibility [9].
In pan-cancer analysis, Hspg2 shows potential as a diagnostic and prognostic marker for bladder urothelial carcinoma and mesothelioma [10].
In conclusion, Hspg2 is essential for multiple biological processes, from development to tissue-specific functions. Its dysregulation or mutation is linked to various diseases, including fibrotic, cardiac, cancerous, and musculoskeletal disorders. Studies on Hspg2, often through mouse models, contribute to understanding disease mechanisms and developing potential therapeutic strategies for these conditions.
References:
1. Zhang, Huimin, Zang, Chengyu, Zhao, Wen, Wu, Jie, Cui, Rongtao. 2023. Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway. In International journal of nanomedicine, 18, 7047-7063. doi:10.2147/IJN.S433510. https://pubmed.ncbi.nlm.nih.gov/38046235/
2. Martinez, Jerahme R, Dhawan, Akash, Farach-Carson, Mary C. 2018. Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions. In Genes, 9, . doi:10.3390/genes9110556. https://pubmed.ncbi.nlm.nih.gov/30453502/
3. Johnson, Benjamin B, Cosson, Marie-Victoire, Tsansizi, Lorenza I, Bernardo, Andreia S, Smith, James G W. 2024. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. In Cell reports, 43, 113668. doi:10.1016/j.celrep.2023.113668. https://pubmed.ncbi.nlm.nih.gov/38198277/
4. Li, Cong, Luo, Pengwei, Guo, Fengzhu, Wang, Shusen, Du, Ting. 2024. Identification of HSPG2 as a bladder pro-tumor protein through NID1/AKT signaling. In Cancer cell international, 24, 345. doi:10.1186/s12935-024-03527-7. https://pubmed.ncbi.nlm.nih.gov/39438949/
5. Zhou, Xiaojia, Liang, Simin, Zhan, Qian, Chi, Jianxiang, Wang, Li. 2020. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia. In Cell death & disease, 11, 492. doi:10.1038/s41419-020-2694-7. https://pubmed.ncbi.nlm.nih.gov/32606327/
6. Zhang, Wenjing, Lin, Zhijuan, Shi, Fuyan, Wang, Suzhen, Wang, Qinghua. 2022. HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer. In Cancers, 14, . doi:10.3390/cancers14143495. https://pubmed.ncbi.nlm.nih.gov/35884556/
7. Gerdes Gyuricza, Isabela, Barbosa de Souza, Rodrigo, Farinha-Arcieri, Luis Ernesto, Ribeiro Fernandes, Gustavo, Veiga Pereira, Lygia. 2020. Is HSPG2 a modifier gene for Marfan syndrome? In European journal of human genetics : EJHG, 28, 1292-1296. doi:10.1038/s41431-020-0666-0. https://pubmed.ncbi.nlm.nih.gov/32514132/
8. Brugnoni, Raffaella, Marelli, Daria, Iacomino, Nicola, Maggi, Lorenzo, Ardissone, Anna. 2023. Novel HSPG2 Gene Mutation Causing Schwartz-Jampel Syndrome in a Moroccan Family: A Literature Review. In Genes, 14, . doi:10.3390/genes14091753. https://pubmed.ncbi.nlm.nih.gov/37761893/
9. Liu, Huahui, Huang, Wen. . The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis. In Iranian journal of public health, 48, 1945-1951. doi:. https://pubmed.ncbi.nlm.nih.gov/31970092/
10. Chen, Fangjun, Gu, Xing, Qiang, Guangliang. 2025. Comprehensive pan-cancer analysis of HSPG2 as a marker for prognosis. In BMC medical genomics, 18, 33. doi:10.1186/s12920-025-02103-w. https://pubmed.ncbi.nlm.nih.gov/39956899/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen